Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Reducing taxes on retirement income is crucial for financial health. Explore effective methods to retain more of your earnings.
20,007 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Weekend reads aren’t just for leisure—they’re a powerful way to sharpen investing judgment. This guide blends long-fo...
SK hynix joins Nasdaq signals AI memory demand, but a Nasdaq-100 semiconductor stock could offer a stronger upside in...
Salesforce faces a growth hurdle in a fast-moving AI world. This article explains how a targeted acquisition could fi...
Samara unveils Locale by Samara, its first single-family model in California, aiming to ease housing shortages by bui...
Velocity closes a $38 million Series A to scale stablecoin-enabled payments for cross-border settlements, backed by a...
Supreme Court justices testified before a House panel seeking more security funding as threats against them grow. Bar...
Official Q2 data show china’s economy slows weakest in over three years, with 4.3% annualized growth as domestic dema...
Regulators worldwide are accelerating a shift from perpetual swaps perpetual to regulated perpetual CFDs, reshaping a...
A major DeFi platform suffered a five-minute security incident on July 15, 2026, tied to forward-dated price feeds. E...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...
A volatile chip market creates both risk and opportunity. This guide highlights two standout bets—NVIDIA and Marvell—...